Neobiomics held its Annual General Meeting for the fiscal year 2022. We were grateful for the support of our investors, board members, and coworkers. In addition to formal presentations about the previous year’s operations, our goal was for us to interact and stay up to… Read More »Annual General Meeting, 2023
Carla Martino holds a background in Industrial Biotechnology from Italy. She has over 3 years of experience in the pharmaceutical industry in different therapeutic areas. Here’s an interview with Carla… Could you tell us about yourself? My name is Carla and I like to think… Read More »Bringing creative vision to life
Neobiomics attended the Annual Preterm Symposium in Cologne, Germany & the British Association of Perinatal Medicine’s Spring Conference in Edinburgh We participated in the Annual Preterm Symposium in Cologne, Germany, on April 22, 2023, which was very well organized by Dr Angela Kribs. Frank Alkenbrecher represented… Read More »Neobiomics: April 2023
Team Neobiomics was happy to participate in the DRIVE Investor Day 2023, organized by Karolinska Instititet Innovation AB. With several companies participating in this event, we were represented by Stefan Johansson, CEO. This allowed us to present Neobiomics, our current and future goals. We saw… Read More »DRIVE Investor Day 2023
As Easter approaches, we’d like to wish everyone a joyful and peaceful holiday. We hope this season brings in a bounty of hope, happiness, and health. We appreciate your continued support and confidence in our company. As we move forward, we hope to strengthen our… Read More »Easter 2023!